(Q54339440)

28 May 2018

title

Podoplanin expression during dysplasia-carcinoma sequence in the oral cavity. (English)

1 reference

28 May 2018

author name string

Harumi Inoue

1

1 reference

28 May 2018

Yuji Miyazaki

2

1 reference

28 May 2018

Kentaro Kikuchi

3

1 reference

28 May 2018

Noriaki Yoshida

4

1 reference

28 May 2018

Fumio Ide

5

1 reference

28 May 2018

Yoshihiro Ohmori

6

1 reference

28 May 2018

Akihito Tomomura

7

1 reference

28 May 2018

Hideaki Sakashita

8

1 reference

28 May 2018

Kaoru Kusama

9

1 reference

28 May 2018

publication date

12 November 2011

1 reference

28 May 2018

published in

Tumor Biology

1 reference

28 May 2018

volume

33

1 reference

28 May 2018

issue

1

1 reference

28 May 2018

page(s)

183-194

1 reference

28 May 2018

Focus on head and neck cancer

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

T1 alpha protein is developmentally regulated and expressed by alveolar type I cells, choroid plexus, and ciliary epithelia of adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

The significance of podoplanin expression in human inflamed gingiva

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Intrapericardial lymphangioma with podoplanin immunohistochemical characterization of lymphatic endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Podoplanin is expressed in subsets of tumors of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Podoplanin is a novel fos target gene in skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

The potential role of podoplanin in tumour invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Significance of podoplanin expression in keratocystic odontogenic tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

pp60c-src activation in human colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Src phosphorylates Cas on tyrosine 253 to promote migration of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

SRC induces podoplanin expression to promote cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0261-7

CD9 Expression on Lymphatic Vessels in Head and Neck Mucosa

21 January 2018

1 reference

12 December 2020

Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours

1 reference

12 December 2020

p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma

1 reference

12 December 2020

The role of podoplanin in tumor progression and metastasis.

1 reference

12 December 2020

Integration of transcriptional signals at the tumor cell invasive front.

1 reference

12 December 2020

Molecular markers of the risk of oral cancer

1 reference

12 December 2020

Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.

1 reference

12 December 2020

Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma

1 reference

12 December 2020

Overexpression of podoplanin in oral cancer and its association with poor clinical outcome

1 reference

12 December 2020

Expression of pp60c-src protein kinase in adult and fetal human tissue: high activities in some sarcomas and mammary carcinomas.

1 reference

12 December 2020

Expression of Podoplanin in Epithelial Ovarian Carcinomas and its Potential as a Marker for Clear Cell Adenocarcinoma

1 reference

12 December 2020

Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations

1 reference

12 December 2020

Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product.

1 reference

12 December 2020

Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis

1 reference

12 December 2020

Lymphatic vascular endothelial hyaluronan receptor (LYVE)-1- and CCL21-positive lymphatic compartments in the diabetic thymus

1 reference

12 December 2020

Enhanced expression of podoplanin in ameloblastomas

1 reference

12 December 2020

10.1007/S13277-011-0261-7

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018